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survival, but previously unrecognized complications may 
arise. We analyzed the characteristics of severe metabolic 
acidosis occurring in 8 of 55 DMD patients, of 20–36 years of 
age, observed over a 5-year period. All patients were on pos-
itive pressure ventilation and were being treated for chronic 
constipation. Before admission, they had had a reduced in-
take of fluids and food. Upon examination, they were severe-
ly ill, dyspneic and suffering from abdominal discomfort. 
Metabolic acidosis with a high anion gap was noted in 5 of 
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 Abstract 
 Duchenne muscular dystrophy (DMD) leads to progressive 
paresis, respiratory failure and premature death. Long-term 
positive pressure ventilation can improve quality of life and 
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Established Facts
 • Long-term ventilation has improved the quality of life and prognosis of patients with Duchenne 
 muscular dystrophy (DMD), but with prolonged survival, previously unrecognized complications can 
emerge. 
Novel Insights
 • We observed an unexpectedly high incidence of severe metabolic acidosis in DMD patients of 20–
36  years of age, in association with chronic constipation, a reduction of fluid and food intake and 
 respiratory infection. Fluid resuscitation, nutrition, regulation of bowel movements and administration 
of  antibiotics led to rapid recovery in all patients, suggesting that progression to a life-threatening 
 condition may be prevented if this particular risk is recognized and appropriate treatment is established 
at an early stage. 
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the 8 patients and with a normal anion gap in the other 3. 
They all recovered after the administration of fluids and nu-
trition, the regulation of bowel movements and treatment 
with antibiotics, as appropriate. Metabolic acidosis is a life-
threatening, potentially preventable complication in older 
DMD patients. Early recognition, subsequent administration 
of fluids, nutrition and antibiotics and regulation of bowel 
movements seem to be essential.  © 2014 S. Karger AG, Basel 
 Introduction 
 Duchenne muscular dystrophy (DMD) is the most 
common form of the inherited muscular dystrophies af-
fecting approximately one in 3,300 male births. The dis-
order is caused by mutations in the gene located at Xp21, 
which codes for the dystrophin protein  [1] . DMD leads to 
progressive muscular weakness, tetraparesis with loss of 
ambulation and chronic respiratory failure at around the 
age of 9, 14 and 20 years, respectively  [2, 3] . Long-term 
mechanical ventilation improves quality of life and has 
increased the life expectancy to approximately 35 years 
 [4] . With prolongation of life, previously unrecognized 
DMD complications can arise. Over the last few years, we 
observed an unexpectedly high incidence of severe, life-
threatening metabolic acidosis in a cohort of adult DMD 
patients. The purpose of this report is to describe the clin-
ical presentation, potential causes and treatment of the 
affected patients in order to promote awareness of this 
potentially preventable complication.
 Case Series 
 The Pulmonary Division at the University Hospital of Zurich 
provides medical services to a cohort of DMD patients. This in-
cludes a yearly clinical examination, blood gas analysis, spirometry 
and general medical care. Patients are referred to other specialists 
as needed. All of the patients reside and/or attend school or work 
in a long-term care facility specialized in muscular dystrophy care, 
the Mathilde Escher Heim  [3, 4] . Patients attending our clinic are 
at least 16 years old. From February 2005 to November 2010, 8 of 
the cohort of 55 patients were admitted to the emergency room of 
our hospital with severe metabolic acidosis, and these 8 represent 
the study group. Their medical records were analyzed retrospec-
tively with the approval of the hospital ethics committee.
 The clinical characteristics and laboratory results of the pa-
tients are presented in  table 1 . At admission, all 8 patients (during 
9 episodes of admission) suffered from dyspnea, despite assisted 
ventilation by mask (n = 7) or tracheostomy (n = 1). They report-
ed abdominal discomfort and distension. All were on long-term 
treatment for chronic constipation with laxatives and enemas. In 
5 patients, this treatment had been intensified on the days before 
admission. All patients had reduced their food and fluid intake 
1–5 days before admission. Two patients presented with recent-
onset cough and purulent sputum. Clinical examination revealed 
that all the patients were in a severely reduced general condition 
with tachycardia (median 130 beats/min, range 96–156), a mean 
arterial blood pressure of 93 mm Hg (range 75–103) and a median 
body temperature of 37.5  °  C (range 36.5–40.0). The laboratory re-
sults at admission on assisted ventilation and supplemental oxygen 
titrated to maintain SpO 2 >90% are listed in  table 1 . The arterial 
pH and bicarbonate were low. The anion gap was elevated in 5 of 
the 9 episodes of admissions. Urinary ketones were qualitatively 
positive in all the cases. Further details of the individual acid-base 
disorders are listed in  table 1 . Patients with a high anion gap met-
abolic acidosis combined with bicarbonate loss and ketoacidosis 
had the lowest pH, despite hyperventilation. The median left ven-
tricular ejection fraction measured in the 8 patients by echocar-
diography was 52% (range 33–60) with values <55% in 5 cases. 
Rehydration, parenteral and/or enteral nutrition, pharmacological 
regulation of intestinal motility and administration of antibiotics 
led to a complete recovery in all patients. Due to the severity of the 
acidosis, case 1 received bicarbonate infusions and case 2 needed 
hemofiltration. Six patients received vitamins and substitution of 
micronutrients. The pH normalized within 12–48 h (mean 36 h 
and SD 12 h) and clinical improvement occurred within 2–4 days 
(mean 2.3 days and SD 1.0 days). The length of hospital stay was 
3–38 days.
 Discussion 
 We describe a case series of 8 DMD patients requiring 
emergency care for severe metabolic acidosis. This condi-
tion has, to our knowledge, not yet been described as a 
common complication in DMD patients. As some of the 
factors that contributed to the life-threatening condition 
of these patients can be prevented if recognized early, it is 
important for physicians to be aware of this potential risk.
 A combination of factors led to a severe acidosis in the 
patients with the lowest pH. The typical causes of meta-
bolic acidosis were ketoacidosis in katabolic states due to 
acute disease exacerbation and fasting, low bicarbonate 
because of intestinal loss and inadequate ventilatory com-
pensation. There was no lactacidosis or indication of in-
toxication to explain the severe acidosis  [5–8] . Several po-
tential pathophysiological mechanisms discussed below 
might have been responsible for the metabolic acidosis in 
the patients described.
 In our experience, many adult DMD patients suffer 
from chronic constipation and require regular use of lax-
atives and enemas  [9] . This promotes metabolic acidosis 
by intestinal loss of bicarbonate. The reasons for chronic 
constipation are not fully understood, but immobility 
seems to play a role. Furthermore, the lack of dystrophin 
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Table 1.  Clinical patient characteristics and laboratory data
Clinical
presentation
Arterial blood gas
analysis
K+
mmol/l
Cl–
mmol/l
AG
mmol/l
Lactate
mmol/l
CRP
mg/l
Urinary
Ketone
Acidotic disorder and suspected 
mechanism
Case 1
Age: 27 years
DID: 73
PPV: 24 h/day by mask
Acute megacolon
pH 7.03
PaCO2 28 mm Hg
HCO3– 8.6 mmol/l
4.3 117 23.4 0.6 125 ++ combined high anion gap 
hyperchloremic acidosis combined 
with moderate ketoacidosis due to 
insufficient caloric intake, intestinal 
bicarbonate loss and dehydration 
Case 2
Age: 20 years
DID: 69
PPV: 24 h/day by mask
Hypoalimentation
pH 7.04
PaCO2 17 mm Hg
HCO3– 4.4 mmol/l
3.2 103 37.6 1 21 ++++ high anion gap metabolic acidosis 
with adequate bicarbonate 
compensation, and ketoacidosis 
due to insufficient caloric intake
Case 3.1
Age: 27 years
DID: 69
PPV: 24 h/day, by trach
Hypoalimentation
pH 6.98
PaCO2 24 mm Hg
HCO3– 5.7 mmol
3.8 103 26.3 0.8 119 +++ high anion gap metabolic acidosis 
with adequate bicarbonate 
compensation, ketoacidosis due to 
insufficient caloric intake, plus 
possible D-lactate acidosis
Case 3.2
Age: 31 years
DID: 72
PPV: 24 h/day by trach
Pneumonia
pH 7.02
PaCO2 26 mm Hg
HCO3– 6.5 mmol
3.9 110 8 0.7 333 +++ normal anion gap hyperchloremic 
metabolic acidosis and 
ketoacidosis due to infection with 
dehydration and bicarbonate loss
Case 4
Age: 22 years
DID: 67
PPV: 8 h/day by mask
Viral gastroenteritis
pH 7.01
PaCO2 18 mm Hg
HCO3– 5.4 mmol
3.3 112 23.6 0.7 77 ++++ combined high anion gap 
hyperchloremic metabolic acidosis, 
ketoacidosis due to insufficient 
caloric intake, intestinal 
bicarbonate loss and dehydration
Case 5
Age: 36 years
DID: 76
PPV: 24 h/day by mask
Acute megacolon
pH 7.29
PaCO2 19 mm Hg
HCO3– 9.1 mmol
2.5 118 11.9 0.5 28 ++ normal anion gap hyperchloremic 
metabolic acidosis due to 
intestinal bicarbonate loss and 
dehydration
Case 6
Age: 21 years
DID: 62
PPV: 8 h/day by mask
Pneumonia
pH 7.26
PaCO2 51 mm Hg
HCO3– 21.9 mmol
3.4 101 14.1 0.7 125 ++++ high anion gap normochloremic 
combined metabolic and 
respiratory acidosis, dehydration
Case 7
Age: 28 years
DID: 76
PPV: 8 h/day by mask
Acute megacolon
pH 7.17
PaCO2 50 mm Hg
HCO3– 16.3 mmol
4.4 114 11.7 0.4 196 +++ normal anion gap hyperchloremic 
combined metabolic and 
respiratory acidosis, moderate 
ketoacidosis and intestinal 
bicarbonate loss
Case 8
Age: 24 years
DID: 71
PPV: 24 h/day by mask
Acute cholecystitis
pH 7.29
PaCO2 31 mm Hg
HCO3– 14.4 mmol
3.6 113 12.7 1.5 122 +++ normal anion gap hyperchloremic 
metabolic acidosis, intestinal 
bicarbonate loss
 AG = Anion gap; CL– = serum chloride concentration; CRP = serum C-reactive protein concentration; DID = Duchenne Muscular 
Dystrophy Physical Impairment and Disability score ranging from 9, no disability to 80, complete dependency on care [4]; K+ = serum 
potassium concentration; lactate = serum lactate concentration; PPV = positive pressure ventilation; trach = by tracheostomy; urinary 
ketone = qualitative ketone concentration.
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as an anchor for nitric oxide synthase is a possible cause 
of low intestinal nitric oxide levels and therefore may im-
pair intestinal relaxation  [10–12] . Chronic dysmotility 
may also lead to intestinal bacterial overgrowth, a risk fac-
tor for D-lactacidosis. In this study, D-lactacidosis was 
evaluated only in patient 8, although it was suspected in 
case 3 at the first admission because of the extremely low 
pH recorded, which was not fully explained by the mea-
sured ketone bodies. Starvation and katabolic metabo-
lism due to acute infection predisposes to ketoacidosis. 
Moreover, dehydration may have led to diminished urine 
output and to reduced excretion of titrable acids such as 
beta-hydroxybutyrate. This may have promoted consti-
pation and led to the laxative therapy. Available data sug-
gest that several of the discussed causes of metabolic aci-
dosis may have been relevant in our case series ( table 1 ). 
We found both high anion gap acidosis (cases 1, 2, 3.1, 4 
and 6) and normal anion gap acidosis (cases 3.2, 5, 7 and 
8). It appears that the severe metabolic acidosis with a pH 
<7.05 in cases 1–4 was due to a combination of factors 
including ketoacidosis. Moderate metabolic acidosis with 
a pH of approximately 7.25–7.3 was related to the gastro-
Evaluation of DMD patients with abdominal discomfort
History
&KDUDFWHULVWLFVRIDEGRPLQDOGLVFRPIRUWQXWULWLRQDOKDELWVIOXLGLQWDNH
 ERZHOPRYHPHQWVOD[DWLYHXVHPHGLFDWLRQ
'\VSQHDFRXJKH[SHFWRUDWLRQ
)HYHURWKHUVLJQVDQGSRWHQWLDOIRFLRILQIHFWLRQ
Physical examination
9LWDOVLJQVWHPSHUDWXUHEORRGSUHVVXUHSXOVHUDWHEUHDWKUDWH
&DUGLDFDQGSXOPRQDU\DXVFXOWDWLRQ
$EGRPLQDOGLVWHQWLRQWHQGHUQHVVERZHOVRXQGV
Ultrasound, radiologic imaging
$EGRPLQDOXOWUDVRXQG&7DEGRPHQFKHVWUDGLRJUDSKDVDSSURSULDWH
Laboratory studies
%ORRGFRXQWHOHFWURO\WHVSKRVSKDWH&UHDFWLYHSURWHLQJOXFRVH
$UWHULDOEORRGJDVDQDO\VLV
pH 7.35
(YDOXDWHDQGWUHDW
DVDSSURSULDWH
pH <7.35
'HWHUPLQHW\SHRIDFLGRVLVUHVSLUDWRU\PHWDEROLF
&DOFXODWHDQLRQJDSPHDVXUHVHUXPODFWDWHXULQDU\
 NHWRQHV
$VVHVVSRVVLEOHH[WHUQDODGPLQLVWUDWLRQRIDFLGV
 LQWR[LFDWLRQELFDUERQDWHORVV
Treatment of metabolic acidosis
$GPLQLVWUDWLRQRIIOXLGVHOHFWURO\WHV
 SKRVSKDWHELFDUERQDWHYLWDPLQVDQG
 WUDFHHOHPHQWVDVDSSURSULDWH
(QWHUDORISDUHQWHUDOIHHGLQJ
5HJXODWLRQRIERZHOPRYHPHQWV
$QWLELRWLFV
$GMXVWPHQWRIYHQWLODWRUVHWWLQJVDV
 DSSURSULDWH
+HDUWIDLOXUHWKHUDS\
Monitoring
$FLGEDVHVWDWXV
)OXLGVWDWXVXULQDU\RXWSXWQXWULWLRQ
(OHFWURO\WHVODFWDWHJOXFRVH
%RZHODFWLYLW\
9HQWLODWLRQDQGR[\JHQDWLRQ
&DUGLRYDVFXODUFRQGLWLRQ
7HPSHUDWXUHVLJQVRILQIHFWLRQ
Fig. 1. Flowchart for assessment and treat-
ment of patients with DMD admitted to the 
hospital with abdominal discomfort. Of 
note, this chart focuses on metabolic acido-
sis and does not provide a comprehensive 
account of all necessary assessments and 
treatments.
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intestinal loss of bicarbonate from diarrhea or after forced 
laxative therapy by enema in cases 5–8. As most of the 
patients had impaired left ventricular function consistent 
with cardiomyopathy, congestive heart failure may have 
aggravated the metabolic acidosis. Serum lactate levels 
were not elevated, however.
 Our observations in older DMD patients on long-term 
ventilation demonstrate that severe metabolic acidosis re-
lated to chronic constipation and its treatment as well as 
reduced fluid and food intake and associated respiratory 
infection constitute a previously unrecognized complica-
tion of DMD. The result may be a life-threatening condi-
tion. We suggest that immediate administration of ade-
quate amounts of fluid and nutrition, the regulation of 
bowel movements and treatment with antibiotics, as ap-
propriate, might be essential for the prevention and treat-
ment of this condition. A flow-chart with the suggested 
practical management is shown in  figure 1 . We recom-
mend that patients with DMD or other advanced neuro-
muscular diseases predisposing to serious complications 
such as those described here are referred for treatment in 
specialized centers.
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